Abstract:Background: Vascularized composite allotransplantation (VCA) offers the potential for a biological, functional reconstruction in individuals with limb loss or facial disfigurement. Yet, it faces substantial challenges due to heightened immune rejection rates compared to solid organ transplants. A deep understanding of the genetic and immunological drivers of VCA rejection is essential to improve VCA outcomes. Methods: Heterotopic porcine hindlimb VCA models were established and followed until reaching the endpoint. Skin and muscle samples were obtained from VCA transplant recipient pigs for histological assessments and RNA sequencing analysis. The rejection groups included recipients with moderate pathological rejection, treated locally with tacrolimus encapsulated in triglycerol-monostearate gel (TGMS-TAC), as well as recipients with severe end-stage rejection presenting evident necrosis. Healthy donor tissue served as controls. Bioinformatics analysis, immunofluorescence, and electron microscopy were utilized to examine gene expression patterns and the expression of immune response markers. Results: Our comprehensive analyses encompassed differentially expressed genes, Gene Ontology, and Kyoto Encyclopedia of Genes and Genomes pathways, spanning various composite tissues including skin and muscle, in comparison to the healthy control group. The analysis revealed a consistency and reproducibility in alignment with the pathological rejection grading. Genes and pathways associated with innate immunity, notably pattern recognition receptors (PRRs), damage-associated molecular patterns (DAMPs), and antigen processing and presentation pathways, exhibited upregulation in the VCA rejection groups compared to the healthy controls. Our investigation identified significant shifts in gene expression related to cytokines, chemokines, complement pathways, and diverse immune cell types, with CD8 T cells and macrophages notably enriched in the VCA rejection tissues. Mechanisms of cell death, such as apoptosis, necroptosis and ferroptosis were observed and coexisted in rejected tissues. Conclusion: Our study provides insights into the genetic profile of tissue rejection in the porcine VCA model. We comprehensively analyze the molecular landscape of immune rejection mechanisms, from innate immunity activation to critical stages such as antigen recognition, cytotoxic rejection, and cell death. This research advances our understanding of graft rejection mechanisms and offers potential for improving diagnostic and therapeutic strategies to enhance the long-term success of VCA.

Circulating Pig-Specific Dna As A Novel Biomarker For Monitoring Xenograft Rejection

CD86 Blockade in Genetically Modified Porcine Cells Delays Xenograft Rejection by Inhibiting T-Cell and NK-Cell Activation

Cellular dynamics in pig-to-human kidney xenotransplantation

Prognostic Value of the Donor-Derived Cell-Free DNA Assay in Acute Renal Rejection Therapy: A Prospective Cohort Study.

Potential Antigens Involved in Delayed Xenograft Rejection in a Ggta1/Cmah Dko Pig-to-Monkey Model

[Xenogeneic Antigens and Immune Response in Pig to Man Xenograft].

Modeling human anti-pig xenoimmune responses in a pig artery tissue grafted humanized mouse model

Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses

Monitoring Porcine Cytomegalovirus in Both Donors and Recipients is Crucial for Recipient's Survival in Pig-to-Cynomolgus Xenotransplantation

Early immune mechanisms of neonatal porcine islet xenograft rejection

Biomarkers from subcutaneous engineered tissues predict acute rejection of organ allografts

Serum Antibody Binding and Cytotoxicity to Pig Cells in Chinese Subjects: Relevance to Clinical Renal Xenotransplantation

Pigs in Transplantation Research and Their Potential as Sources of Organs in Clinical Xenotransplantation

Xenoantigen Deletion and Chemical Immunosuppression Can Prolong Renal Xenograft Survival

Tools for Molecular Studies in Xenotransplantation

Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed?

Anti-pig Antibodies in Swine Veterinarian Serum: Implications for Clinical Xenotransplantation

Spatiotemporal immune atlas of a clinical-grade gene-edited pig-to-human kidney xenotransplant

Porcine PD-L1: cloning, characterization, and implications during xenotransplantation

Porcine endogenous retrovirus encodes xenoantigens involved in porcine cellular xenograft rejection by mice

Transcriptome profiling of immune rejection mechanisms in a porcine vascularized composite allotransplantation model